Activation or suppression of NFκB by HPK1 determines sensitivity to activation-induced cell death

被引:63
|
作者
Brenner, D
Golks, A
Kiefer, F
Krammer, PH
Arnold, R
机构
[1] German Canc Res Ctr, Tumor Immunol Program, D-69112 Heidelberg, Germany
[2] Max Planck Inst Mol Biomed, Munster, Germany
关键词
AICD; apoptosis; IKK; signaling; TCR;
D O I
10.1038/sj.emboj.7600894
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Restimulation of the T-cell receptor (TCR) in activated T cells induces CD95 (Fas/Apo-1)-mediated activation-induced cell death (AICD). The TCR-proximal mechanisms leading to AICD are elusive. Here we characterize hematopoietic progenitor kinase 1 (HPK1) as a differentially regulated TCR-proximal signaling protein involved in AICD of primary T cells. We show that HPK1 is a functional component of the endogenous I kappa B kinase (IKK) complex and is crucial for TCR-mediated NF kappa B activation. While full-length HPK1 enhances IKK beta phosphorylation, siRNA-mediated knockdown of HPK1 blunts TCR-mediated NF kappa B activation and increases cell death. We also demonstrate proteolytic processing of HPK1 into HPK1-C, specifically in AICD-sensitive primary T cells. The cleavage product HPK1-C sequesters the inactive IKK complex and suppresses NF kappa B upon TCR restimulation by binding to IKK alpha and IKK beta. T cells of HPK1-C transgenic mice are sensitized towards TCR-mediated AICD. Consequently, preventing HPK1-C generation in primary T cells by siRNA-mediated knockdown results in decreased AICD. Thus, these results show a novel mechanism of sensitization of T lymphocytes towards AICD by suppression of NF kappa B, and propose that HPK1 is a life/death switch in T lymphocytes.
引用
收藏
页码:4279 / 4290
页数:12
相关论文
共 50 条
  • [21] Ouabain exacerbates activation-induced cell death in human peripheral blood lymphocytes
    Esteves, MB
    Marques-Santos, LF
    Affonso-Mitidieri, OR
    Rumjanek, VM
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2005, 77 (02): : 281 - 292
  • [22] Involvement of IL-32 in activation-induced cell death in T cells
    Goda, C
    Kanaji, T
    Kanaji, S
    Tanaka, G
    Arima, K
    Ohno, S
    Izuhara, K
    INTERNATIONAL IMMUNOLOGY, 2006, 18 (02) : 233 - 240
  • [23] Activation-induced cell death in T lymphocytes from multiple sclerosis patients
    Moreno, Montserrat
    Negrotto, Laura
    Rio, Jordi
    Moubarak, Rana
    Martin, Isabel
    Bustamante, Marta F.
    Comella, Joan X.
    Vidal-Jordana, Angela
    Perez-Boza, Jennifer
    Montalban, Xavier
    Comabella, Manuel
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 272 (1-2) : 51 - 55
  • [24] Mechanism of Activation-Induced Cell Death of T Cells and Regulation of FasL Expression
    Arakaki, Rieko
    Yamada, Akiko
    Kudo, Yasusei
    Hayashi, Yoshio
    Ishimaru, Naozumi
    CRITICAL REVIEWS IN IMMUNOLOGY, 2014, 34 (04) : 301 - 314
  • [25] Interferon γ is required for activation-induced death of T lymphocytes
    Refaeli, Y
    Van Parijs, L
    Alexander, SI
    Abbas, AK
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) : 999 - 1005
  • [26] Activation-induced NK cell death triggered by CD2 stimulation
    Ida, H
    Anderson, P
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (04) : 1292 - 1300
  • [27] A novel role for sphingolipid intermediates in activation-induced cell death in T cells
    Solomon, JC
    Sharma, K
    Wei, LX
    Fujita, T
    Shi, YF
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (02) : 193 - 202
  • [28] Regulation of activation-induced cell death of mature T-lymphocyte populations
    Janssen, O
    Sanzenbacher, R
    Kabelitz, D
    CELL AND TISSUE RESEARCH, 2000, 301 (01) : 85 - 99
  • [29] PRMT1 negatively regulates activation-induced cell death in macrophages by arginine methylation of GAPDH
    Cho, Jun-Ho
    Lee, Rana
    Kim, Eunju
    Choi, Yea Eun
    Choi, Eui-Ju
    EXPERIMENTAL CELL RESEARCH, 2018, 368 (01) : 50 - 58
  • [30] Transmembrane TNF-α promotes activation-induced cell death by forward and reverse signaling
    Zhang, Meng
    Wang, Jing
    Jia, Lingwei
    Huang, Jin
    He, Cheng
    Hu, Fuqing
    Yuan, Lifei
    Wang, Guihua
    Yu, Mingxia
    Li, Zhuoya
    ONCOTARGET, 2017, 8 (38) : 63799 - 63812